AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million at maturity. This refinancing move helps the company manage its debt while continuing to support its operations as a major Baltic Sea port and its subsidiaries in ferry and shipping services. The loan ensures financial stability for ongoing and future projects in cargo, passenger transport, and related maritime services.
Regarding changes in debt obligations of AS Tallinna Sadam, here is Pluang's Financials-sector market snapshot as of Oct 26, 2026 20:32 WIB: Out of 142 priced US Financial stocks, 88 rose and 50 fell today. Marathon Digital Holdings Inc (MARA) traded at USD 6.78 with a 1-day change of -3.42% and a typical hold time of 23 days, contrasting with Riot Platforms Inc (RIOT) at USD 12.16, down 2.95%, held typically for 17 days. Corebridge Financial Inc (CRBG) stood out with a price of USD 35.03, up 2.64%, and a shorter hold time of 8 days.
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
Neo Security has named Scott Stout as its new Chief Revenue Officer to lead global revenue growth and expand sales of its agentic software security platform. Stout brings over 20 years of cybersecurity experience, including leadership roles at Cisco ...
ThredUp's 2026 Holiday Resale Report reveals that 62% of Americans intend to buy secondhand gifts this holiday season, with 55% preferring unique, vintage items over brand-new ones. Shoppers are allocating about 37% of their gift budget to secondhand...
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...
